September 28, 2022
Loading...
You are here:  Home  >  Latest news  >  Current Article

Westlake Village BioPartners leads $85 million investment to fight cancer

IN THIS ARTICLE

Tri-county biotech investment firm Westlake Village BioPartners led an $85 million Series A investment in South San Francisco cell therapy and drug discovery startup Arsenal Biosciences. The company will leverage technologies such as CRISPR and a machine learning platform to scale up the process of identifying new drug targets and developing immune cell therapies, starting…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.